These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22021102)

  • 1. Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease.
    Mazari FA; Khan JA; Carradice D; Samuel N; Abdul Rahman MN; Gulati S; Lee HL; Mehta TA; McCollum PT; Chetter IC
    Br J Surg; 2012 Jan; 99(1):39-48. PubMed ID: 22021102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication.
    Mazari FA; Gulati S; Rahman MN; Lee HL; Mehta TA; McCollum PT; Chetter IC
    Ann Vasc Surg; 2010 Jan; 24(1):69-79. PubMed ID: 19762206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease.
    Mazari FA; Khan JA; Samuel N; Smith G; Carradice D; McCollum PC; Chetter IC
    Br J Surg; 2017 Jan; 104(1):76-83. PubMed ID: 27763685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic analysis of a randomized trial of percutaneous angioplasty, supervised exercise or combined treatment for intermittent claudication due to femoropopliteal arterial disease.
    Mazari FA; Khan JA; Carradice D; Samuel N; Gohil R; McCollum PT; Chetter IC
    Br J Surg; 2013 Aug; 100(9):1172-9. PubMed ID: 23842831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease.
    Mazari FA; Carradice D; Rahman MN; Khan JA; Mockford K; Mehta T; McCollum PT; Chetter IC
    J Vasc Surg; 2010 Jul; 52(1):77-84. PubMed ID: 20471779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease.
    Greenhalgh RM; Belch JJ; Brown LC; Gaines PA; Gao L; Reise JA; Thompson SG;
    Eur J Vasc Endovasc Surg; 2008 Dec; 36(6):680-8. PubMed ID: 19022184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients.
    Wilson SE
    Ann Vasc Surg; 2010 May; 24(4):498-502. PubMed ID: 20036508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of exercise training or percutaneous transluminal angioplasty for intermittent claudication.
    Frans FA; Bipat S; Reekers JA; Legemate DA; Koelemay MJ
    Br J Surg; 2012 Jan; 99(1):16-28. PubMed ID: 21928409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication.
    Lee HL; Mehta T; Ray B; Heng MS; McCollum PT; Chetter IC
    Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):202-7. PubMed ID: 17142065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUPERvised exercise therapy or immediate PTA for intermittent claudication in patients with an iliac artery obstruction--a multicentre randomised controlled trial; SUPER study design and rationale.
    Frans FA; Bipat S; Reekers JA; Legemate DA; Koelemay MJ;
    Eur J Vasc Endovasc Surg; 2012 Apr; 43(4):466-71. PubMed ID: 22326696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
    Kakkos SK; Geroulakos G; Nicolaides AN
    Eur J Vasc Endovasc Surg; 2005 Aug; 30(2):164-75. PubMed ID: 15890545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regarding "an analysis of relationship between quality of life indices and clinical improvement following intervention in patients with intermittent claudication due to femoropopliteal disease".
    Frans FA; Koelemay MJ
    J Vasc Surg; 2011 Apr; 53(4):1164; author reply 1164. PubMed ID: 21439465
    [No Abstract]   [Full Text] [Related]  

  • 13. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
    Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
    Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The constitutive procoagulant and hypofibrinolytic state in patients with intermittent claudication due to infrainguinal disease significantly improves with percutaneous transluminal balloon angioplasty.
    Hobbs SD; Marshall T; Fegan C; Adam DJ; Bradbury AW
    J Vasc Surg; 2006 Jan; 43(1):40-6. PubMed ID: 16414385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication.
    Nylaende M; Abdelnoor M; Stranden E; Morken B; Sandbaek G; Risum Ø; Jørgensen JJ; Lindahl AK; Arnesen H; Seljeflot I; Kroese AJ
    Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):3-12. PubMed ID: 17055756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates--randomized controlled trial.
    Amighi J; Schillinger M; Dick P; Schlager O; Sabeti S; Mlekusch W; Haumer M; Mathies R; Heinzle G; Schuster A; Loewe C; Koppensteiner R; Lammer J; Minar E; Cejna M
    Radiology; 2008 Apr; 247(1):267-72. PubMed ID: 18270378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does percutaneous transluminal angioplasty improve quality of life?
    Keeling AN; Naughton PA; O'Connell A; Lee MJ
    J Vasc Interv Radiol; 2008 Feb; 19(2 Pt 1):169-76. PubMed ID: 18341944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance phase contrast velocity measurement for non-invasive follow up after percutaneous transluminal angioplasty.
    Heverhagen JT; Wagner HJ; Bandorski D; Hoppe M; Alfke H
    Vasa; 2002 Nov; 31(4):235-40. PubMed ID: 12510547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial.
    Whyman MR; Fowkes FG; Kerracher EM; Gillespie IN; Lee AJ; Housley E; Ruckley CV
    J Vasc Surg; 1997 Oct; 26(4):551-7. PubMed ID: 9357454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-year results from a randomized clinical trial of revascularization in patients with intermittent claudication.
    Nordanstig J; Taft C; Hensäter M; Perlander A; Österberg K; Jivegård L
    Br J Surg; 2016 Sep; 103(10):1290-9. PubMed ID: 27220310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.